Holland Capital becomes member of the German Private Equity and Venture Capital Association

Düsseldorf/Amsterdam, 20 September 2022 – As of September 2022 Holland Capital is a full member of The German Private Equity and Venture Capital Association (BVK). With this membership, Holland Capital confirms its commitment to the German private equity market.

BVK: face and voice of the private equity industry

BVK is the face and voice of the private equity industry in Germany, they campaign for improvements to the fiscal environment and for easier access to private equity so that even more companies in Germany can benefit from private equity. BVK takes a stand on policy issues and the media in an effort to underline how important private equity is for the German economy. They observe the market and analyse its trends, as private equity can be a growth engine for innovation, start-ups and SME’s. www.bvkap.de

Holland Capital is committed to the German market

Ewout Prins, managing partner Holland Capital, “Holland Capital has been active for over 40 years as a private equity investor within the Healthcare and Technology sectors in the Dutch market. We see interesting opportunities in the German market for our investment strategy. To support the expansion of our activities into the German market, we opened our Düsseldorf office last year. We look forward to working with German entrepreneurs, investors and advisers. As such, we are pleased to have become member of the BVK. We shall be happy to contribute to the German Private Equity industry”.

About Holland Capital

Over the past 40 years, Holland Capital has responsibly and successfully invested in over more than 150 SME-companies. With a clear investment strategy Holland Capital is active in the attractive growth markets of Healthcare and Technology. Holland Capital’s experienced and committed investment team aims to establish an open, sustainable, and professional relationship with the companies they invest in, with the common goal of achieving growth. Holland Capital is backed by a broad network of successful entrepreneurs in the relevant growth markets and has her offices in Amsterdam (NL) and Düsseldorf (D).

Defibrion acquires Defibsolutions and expands its business

Defibrion acquires Defibsolutions and expands its business

Amsterdam, 1 November 2022 - Our portfolio company Defibrion acquires DefibSolutions, a wholesaler of AEDs and resuscitation products. By joining forces, Defibrion strengthens its market position in AEDs and related products & services in the field of emergency...

Channext raises €4.5M Series A funding

Channext raises €4.5M Series A funding

Utrecht, 27 September 2022 - Partner marketing platform Channext has raised €4.5 million in funding. The series A round is led by Holland Capital, investing together with the Graduate Entrepreneur Fund and current investors. With this funding, Channext aims to become...

Mauritskliniek joins CORIUS

Mauritskliniek joins CORIUS

NZa approval for acquisition of Mauritskliniek by CORIUS Amsterdam, 16 September 2022 – The Dutch Healthcare Authority has given its approval to the proposed acquisition of our portfolio company Mauritskliniek by CORIUS. Mauritskliniek (incl. Kliniek Veldhoven)...

Holland Capital invests in ComplianceWise

Holland Capital invests in ComplianceWise

Amsterdam, 6 September 2022 - Investment company Holland Capital provides growth finance to ComplianceWise, a SaaS company that offers solutions to financial institutions and service providers such as accountants and tax advisors. These partners deal with growing...

Eshgro attracts new investor for further growth

Eshgro attracts new investor for further growth

Boxmeer/Blaricum, August 31, 2022 - Strikwerda Investments (SI) becomes the new majority shareholder of IT service provider Eshgro, headquartered in Boxmeer (NL) and merges Eshgro with its portfolio company Total Specific Hosting (TSH). SI takes a majority share in...

Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 311 94 11

 

Düsseldorf
Inselstraße 34
40479 Düsseldorf
+49 (0) 211 43 63 69 01